Yale University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Yale University sits in the top decile of US sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count).
Yale University: 1,492 sponsored US clinical trials, 254 recruiting.
Yale University sponsors 1,492 registered US clinical trials on ClinicalTrials.gov, 254 of them currently recruiting, and 1,005 completed. 99 of these trials are in Phase 3-4 (later-stage) and 579 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 19 trials.
Top-decile sponsor footprint
Yale University ranks in the top decile of sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,005 of 1,138 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,492 total, page 14 of 30
A Team-based Approach to Improve Knowledge and Judgment Performance in Electronic Fetal Monitoring
NCT04040257
Multimodal Sleep Intervention Using Wearable Technology
NCT03658954
Translating Neuroprediction Into Precision Medicine Via Brain Priming
NCT03370510
Cognitive-Behavioral and Physical Activity Interventions for Binge Eating and Overweight
NCT03777189
Feasibility Pilot of Bright Light in the Intensive Care Unit
NCT03568045
Zero Sodium Peritoneal Dialysate Protocol Pilot Study
NCT03801226
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial
NCT03367533
White Noise to Improve Sleep in the Medical Intensive Care Unit (MICU): a Pilot and Feasibility Study
NCT03755011
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
NCT03352245
Nutrition and Prostate Cancer
NCT03532308
Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis
NCT03684187
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
NCT03356483
Validating Imaging Biomarkers of Small Vessel Disease in Diabetic Individuals Using Advanced MRI Techniques.
NCT03754608
Mechanisms for Restoration of Hypoglycemia Awareness
NCT03738852
Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes
NCT03714451
An Accessible Digital Intervention to Promote HIV Testing/Counseling and Prevention Among Adolescents
NCT03713034
Influence of Medication on Functional Connectivity
NCT03612713
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
NCT03410654
Comparing an Inexpensive Handheld Ultrasound Machine and a Large Mobile Ultrasound System
NCT03764111
OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings
NCT03651453
Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID)
NCT04255381
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
NCT03438682
The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders
NCT03872128
Digital Parent Training for Disruptive Behaviors in Children
NCT03697837
Adapting an Evidence-based Intervention for Stigma-related Stress, Mental Health, and HIV Risk for MSM of Color in Small Urban Areas
NCT03464422
Improving Pediatric Obesity Practice Using Prompts
NCT03648242
Fatherhood Focused Family Violence Education Program
NCT03883932
Perioperative Blood Pressure Screening to Improve Long-term Cardiovascular Health
NCT03634813
Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders
NCT03585010
The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos)
NCT03371745
Mechanisms of Obesity and Its Metabolic Complications in Youth
NCT03454828
Effect of Mental Imagery Training on Brain Plasticity and Motor Function in Individuals With Parkinson's Disease
NCT03623386
Bariatric Scalable Internet Treatments
NCT03680703
Project EQuIP: Empowering Queer Identities in Psychotherapy
NCT03721276
Cannabis Use and Relapse After One Week of Contingency Management Therapy
NCT04202146
Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure
NCT03446651
Detection of Postoperative Respiratory Depression in High Risk Patients Utilizing Minute Ventilation Monitoring
NCT04017702
Establishing Muscle Impedance Parameters With Electrical Impedance Myography
NCT03633318
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma
NCT03502330
Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
NCT03500484
Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)
NCT04417946
Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone
NCT03375567
Metabotropic Glutamate Receptor-5 (mGlur5) Effects on Reward-Related fMRI-BOLD Activation in FHP and FHN
NCT03341715
Neurofeedback of Amygdala Activity for Post-traumatic Stress Disorder
NCT03574974
The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes
NCT03542682
An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis
NCT03359174
Feasibility of Providing Computerized CBT in the Black Church
NCT03579290
Galantamine and CBT4CBT Pilot to Prevent Relapse.
NCT03547622
Financial Incentives, Randomization With Stepped Treatment Trial
NCT03089320
Effects of Flavors on Nicotine Reinforcement in Smokers
NCT03243630
What is open in the Yale University pipeline
254 recruiting of 1,492 indexed (17% open); 1,005 completed (67%).
Phase mix: 99 late (III/IV) vs 579 early (I/II) (early-phase heavy).
Top condition: Opioid Use Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Yale University: open-pipeline peers nationwide
Peers matched on 1,492 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Yale University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,492 trials (± recruiting share)
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- NYU Langone Health · 17% recruiting · 1,164 trials
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
Related
What to do with this Yale University page
1,492 registered trials is a research-attention snapshot, not an endorsement of Yale University or any single study.
- 254 of Yale University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Yale University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Yale University pipeline card: 1,492 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.